LFCR vs. TELO, ELYM, ALIM, GTHX, VERU, DSGN, ZVRA, ATOS, GBIO, and TRVI
Should you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include Telomir Pharmaceuticals (TELO), Eliem Therapeutics (ELYM), Alimera Sciences (ALIM), G1 Therapeutics (GTHX), Veru (VERU), Design Therapeutics (DSGN), Zevra Therapeutics (ZVRA), Atossa Therapeutics (ATOS), Generation Bio (GBIO), and Trevi Therapeutics (TRVI). These companies are all part of the "pharmaceutical preparations" industry.
Telomir Pharmaceuticals (NASDAQ:TELO) and Lifecore Biomedical (NASDAQ:LFCR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.
83.4% of Lifecore Biomedical shares are owned by institutional investors. 14.6% of Lifecore Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Lifecore Biomedical has a consensus target price of $9.50, suggesting a potential upside of 51.27%. Given Telomir Pharmaceuticals' higher possible upside, analysts clearly believe Lifecore Biomedical is more favorable than Telomir Pharmaceuticals.
Telomir Pharmaceuticals has higher earnings, but lower revenue than Lifecore Biomedical.
In the previous week, Telomir Pharmaceuticals and Telomir Pharmaceuticals both had 1 articles in the media. Lifecore Biomedical's average media sentiment score of 1.89 beat Telomir Pharmaceuticals' score of 0.93 indicating that Telomir Pharmaceuticals is being referred to more favorably in the media.
Lifecore Biomedical received 1 more outperform votes than Telomir Pharmaceuticals when rated by MarketBeat users.
Summary
Lifecore Biomedical beats Telomir Pharmaceuticals on 6 of the 8 factors compared between the two stocks.
Get Lifecore Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Lifecore Biomedical Competitors List
Related Companies and Tools
